Kadcyla 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDL75
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,220
Award facts
- Contract value 100% obligated
- $21,220.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $21,220.32 to DMS Pharmaceutical Group Inc. for the supply of Kadcyla 100 mg vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of October 1, 2025. The contract does not utilize any set-aside designation, allowing the vendor to compete on a competitive basis leveraging its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The parent IDC covers a comprehensive portfolio of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Kadcyla, a branded oncology treatment, aligns with the vendor's demonstrated expertise in delivering specialized pharmaceutical products including biologics and cancer therapies to federal military healthcare systems. The delivery order represents a routine transaction within this established procurement vehicle, reflecting DMS Pharmaceutical Group's critical role as a pharmaceutical supplier to the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FDL75?
SPE2DB25FDL75 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FDL75 worth?
The government has obligated $21,220 on SPE2DB25FDL75.
Is contract SPE2DB25FDL75 an order under another contract?
Yes. SPE2DB25FDL75 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL75 competed?
The extent of competition for SPE2DB25FDL75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award